|
Volumn 28, Issue 2, 1996, Pages 960-963
|
Brequinar sodium
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BREQUINAR;
CYCLOSPORIN A;
URIDINE DERIVATIVE;
ANEMIA;
CLINICAL PROTOCOL;
CLINICAL TRIAL;
CONFERENCE PAPER;
DIARRHEA;
DRUG MECHANISM;
DRUG POTENTIATION;
GRAFT REJECTION;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
INTRAVENOUS DRUG ADMINISTRATION;
LEUKOPENIA;
MUCOSA INFLAMMATION;
NAUSEA;
NONHUMAN;
ORAL DRUG ADMINISTRATION;
PHASE 1 CLINICAL TRIAL;
PRIORITY JOURNAL;
THROMBOCYTOPENIA;
VOMITING;
ANIMALS;
BIPHENYL COMPOUNDS;
CLINICAL TRIALS, PHASE I;
GRAFT REJECTION;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
TRANSPLANTATION IMMUNOLOGY;
|
EID: 0029872481
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
Times cited : (16)
|
References (0)
|